美国 · SEC FORM 4
Grace Therapeutics, Inc.
GRCE · Nasdaq · CIK 0001444192 · Healthcare · Biotechnology
内部人信号
2 位买方 · 16 条买入交易行 · $608.0K 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是:Chief Executive Officer(CEO、董事长和持股 10% 以上的股东得分最低)
- ✓ Recent activity · latest purchase 2026-10-16
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Chief Executive Officer, TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 60.0
- 61.0
- 60.8
- 60.6
- 62.0
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -11.3%
- 3M
- -22.2%
- 6M
- -58.9%
- 12M
- -39.2%
波动率与流动性
- 波动率
- 68.5%
- Beta
- 0.44
- 平均每日成交额
- USD 335,108
估值
- 市值
- USD 30.8M
- P/E
- —
基本面
- 利润率
- 0.0%
- ROE
- -12.2%
- 细分行业
- Biotechnology
市场数据
价格数据截至:2026-10-18 · 价格来源:OpenBB/yfinance · 来自 SEC 申报文件:市值, ROE · 财年截止日:2026-03-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期:2026-06-15 · 来自 Yahoo Finance:利润率 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 1,721,067
- 上期报告
- 1,765,202
- 日均成交量
- 90,442
- 回补天数
- 19.0
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-16 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 36,347 | USD 1.89 | USD 68,758 | SEC 申报 ↗ |
| 2026-10-15 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 23,485 | USD 1.95 | USD 45,685 | SEC 申报 ↗ |
| 2026-10-14 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 11,233 | USD 1.93 | USD 21,735 | SEC 申报 ↗ |
| 2026-10-12 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 7,215 | USD 2.02 | USD 14,574 | SEC 申报 ↗ |
| 2026-10-09 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 5,340 | USD 2.04 | USD 10,918 | SEC 申报 ↗ |
| 2026-10-08 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 2,077 | USD 2.02 | USD 4,190 | SEC 申报 ↗ |
| 2026-10-05 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 1,694 | USD 2.06 | USD 3,490 | SEC 申报 ↗ |
| 2026-10-02 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 20,000 | USD 2.07 | USD 41,368 | SEC 申报 ↗ |
| 2026-10-01 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 38,796 | USD 2.04 | USD 78,961 | SEC 申报 ↗ |
| 2026-09-29 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 7,849 | USD 2.09 | USD 16,404 | SEC 申报 ↗ |
| 2026-09-23 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 5,318 | USD 2.10 | USD 11,168 | SEC 申报 ↗ |
| 2026-09-21 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 9,771 | USD 2.10 | USD 20,519 | SEC 申报 ↗ |
| 2026-09-09 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 5,836 | USD 2.09 | USD 12,197 | SEC 申报 ↗ |
| 2026-09-09 | Kohli Prashant | 买入 (P) | Common Stock | 100,000 | USD 2.14 | USD 214,000 | SEC 申报 ↗ |
| 2026-09-08 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 9,393 | USD 2.10 | USD 19,725 | SEC 申报 ↗ |
Form 4 申报证据
16 transaction lines in the latest 365-day window; 18 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-16 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 36,347 | USD 1.89 | USD 68,758 | SEC 申报 ↗ |
| 2026-10-15 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 23,485 | USD 1.95 | USD 45,685 | SEC 申报 ↗ |
| 2026-10-14 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 11,233 | USD 1.93 | USD 21,735 | SEC 申报 ↗ |
展开近期 Form 4 证据 (16 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-16 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 36,347 | USD 1.89 | USD 68,758 | SEC 申报 ↗ |
| 2026-10-15 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 23,485 | USD 1.95 | USD 45,685 | SEC 申报 ↗ |
| 2026-10-14 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 11,233 | USD 1.93 | USD 21,735 | SEC 申报 ↗ |
| 2026-10-12 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 7,215 | USD 2.02 | USD 14,574 | SEC 申报 ↗ |
| 2026-10-09 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 5,340 | USD 2.04 | USD 10,918 | SEC 申报 ↗ |
| 2026-10-08 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 2,077 | USD 2.02 | USD 4,190 | SEC 申报 ↗ |
| 2026-10-05 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 1,694 | USD 2.06 | USD 3,490 | SEC 申报 ↗ |
| 2026-10-02 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 20,000 | USD 2.07 | USD 41,368 | SEC 申报 ↗ |
| 2026-10-01 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 38,796 | USD 2.04 | USD 78,961 | SEC 申报 ↗ |
| 2026-09-29 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 7,849 | USD 2.09 | USD 16,404 | SEC 申报 ↗ |
| 2026-09-23 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 5,318 | USD 2.10 | USD 11,168 | SEC 申报 ↗ |
| 2026-09-21 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 9,771 | USD 2.10 | USD 20,519 | SEC 申报 ↗ |
| 2026-09-09 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 5,836 | USD 2.09 | USD 12,197 | SEC 申报 ↗ |
| 2026-09-09 | Kohli Prashant | 买入 (P) | Common Stock | 100,000 | USD 2.14 | USD 214,000 | SEC 申报 ↗ |
| 2026-09-08 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 9,393 | USD 2.10 | USD 19,725 | SEC 申报 ↗ |
| 2026-08-14 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.0001 per share | 11,608 | USD 2.09 | USD 24,261 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | GRCE |
| CIK | 0001444192 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 18 transaction lines from 2023-08-31 to 2026-10-16 18 P purchase lines · 0 S sale lines · 0 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.